For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Tenaya Therapeutics, Inc.

USPTO Granted Patents = 14

Forward Citations = 16

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Laura Lombardi (7 out of 7 patents)

Huanyu Zhou (4 out of 4 patents)

Mohammad A Mandegar (4 out of 4 patents)

4. Ulhas Bhatt (3 out of 8 patents)

5. David Sperandio (3 out of 4 patents)

6. Alok Nerurkar (3 out of 6 patents)

7. Snahel Patel (3 out of 33 patents)

8. Tien Widjaja (3 out of 8 patents)

9. Julio Cesar Medina (3 out of 73 patents)

10. Christopher A Reid (2 out of 2 patents)

11. Frederick Seidl (1 out of 4 patents)

12. Pingyu Ding (1 out of 50 patents)

13. Jin Yang (1 out of 1 patent)

14. Chris Reid (1 out of 1 patent)

15. Jaclyn Ho (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12478691 - Gene therapy vectors for treating heart disease (2025-11-25),

2. 12312345 - Fluoroalkyl-oxadiazoles and uses thereof (2025-05-27),

3. 12201617 - HDAC6 inhibitors for treatment of metabolic disease and HFpEF (2025-01-21),

4. 12168778 - Cardiac cell reprogramming with myocardin and ASCL1 (2024-12-17),

5. 12151001 - Optimized expression cassettes for gene therapy (2024-11-26),

6. 12104165 - Adeno-associated virus with engineered capsid (2024-10-01),

7. 11926622 - Fluoroalkyl-oxadiazoles and uses thereof (2024-03-12),

8. 11913012 - Cardiac cell reprogramming with myocardin and ASCL1 (2024-02-27),

9. 11781156 - Plakophillin-2 gene therapy methods and compositions (2023-10-10),

10. 11759531 - Gene therapy vectors for treating heart disease (2023-09-19),

11. 11578066 - Fluoroalkyl-oxadiazoles and uses thereof (2023-02-14),

12. 11446397 - Gene therapy vectors for treating heart disease (2022-09-20),

13. 11129908 - Gene therapy vectors for treating heart disease (2021-09-28),

14. 11015211 - Cardiac cell reprogramming with myocardin and ASCL1 (2021-05-25),

Tenaya Therapeutics is a biotechnology company focused on developing treatments for heart failure and other cardiovascular diseases using cutting-edge regenerative medicine approaches. The company's innovative research and development efforts are aimed at addressing the underlying causes of cardiovascular conditions, with the goal of advancing novel therapies that have the potential to transform patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

14 Patents

#78 in South San Francisco, CA

#5,150 in California

#21,600 in US

#40,903 in the World

South San Francisco, CA, United States of America

Tenaya Therapeutics, Inc.

Forward Citations = 16

21 inventors:

Laura Lombardi (7 out of 7 patents)

Huanyu Zhou (4 out of 4 patents)

Mohammad A Mandegar (4 out of 4 patents)

4. Ulhas Bhatt (3 out of 8 patents)

5. David Sperandio (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…